SCHEMBL8615260

SCHEMBL8615260

CCc1cc2c(cc1OCCN(C)C)NCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
HRH3 Q9Y5N1 1/20 0.36
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4C Q9H3R0 1/20 0.35
HTR7 P34969 3/20 0.34
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34
DRD4 P21917 1/20 0.34
DRD5 P21918 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PARP1 P09874 2/20 0.34
FLT3 P36888 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7752192 0.82 HTR7 (0.42) NOS3NOS1HRH3ALDH1A1HTR7
SCHEMBL8612335 0.82 HTR7 (0.44) HRH3KDM4EALDH1A1HTR7SMN1; SMN2
SCHEMBL7756067 0.82 MAPT (0.40) HRH3KDM4EALDH1A1HTR7DRD2
SCHEMBL8621045 0.82 HRH3 (0.37) HRH3KDM4EHTR7DRD2DRD1
SCHEMBL7094760 0.77 HRH3 (0.52) HRH3KDM4EALDH1A1SMN1; SMN2PARP1
SCHEMBL8389373 0.75 HTR7 (0.40) NOS3NOS1HRH3KDM4EALDH1A1
SCHEMBL9072587 0.74 SMN1; SMN2 (0.45) KDM4EALDH1A1DRD2DRD4SMN1; SMN2
SCHEMBL7756672 0.74 HRH3 (0.38) HRH3KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL15880025 0.73 HRH3 (0.58) HRH3KDM4EALDH1A1PARP1
SCHEMBL9098005 0.72 NR4A2 (0.51) HRH3KDM4EHTR7HTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998050346-A2 ACETAMIDE AND UREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 WO disclosed